Market by Animal Type, Disease Type, Product Type, and Regional Outlook | Forecast 2022-2028
Veterinary vaccines
play a vital role in maintaining animal health and public health by minimizing
animal suffering. This significantly lowers the demand for antibiotics to treat
food & companion animals and enables efficient production of animal food.
Veterinary vaccines are the most cost-effective and sustainable methods of
controlling infectious veterinary diseases. They are administered to companion
animals such as cats and dogs; livestock animals such as cattle, pigs, sheep,
and others; and aquaculture.
According to Triton
Market Research’s report, the Global Veterinary
Vaccines Market is likely to grow with a CAGR of 7.46% in the forecast period 2022-2028. The market was valued at $7086.10 million in 2021
and is expected to reach a revenue of $12119.03
million by 2028.
Click here to check out our blog on the Global Veterinary Vaccines Market
MARKET PERFORMANCE – DRIVERS, CHALLENGES, AND TRENDS
The
market is driven by several factors, such as the high vaccine demand due to the
rising animal population & diseases, government-organized vaccination
drives, and advanced vaccine research & development.
As the demand for animal-derived products rises, animal producers are expanding
their strategies for growing and maintaining a sufficient animal population to
meet the need. The majority of animal infections are viral in nature and move
from one animal to the next. Producers of cattle, swine, poultry, and other
livestock maintain huge numbers of animals together, exposing them to diseases
that can transfer from one animal to the other. As a result, there is a
significant need for vaccinations, which aid and function as a strategy to
prevent illnesses from spreading widely and to minimize or control their
spread. Thus, the market’s expansion is aided by the rising vaccination demand.
On
the other hand, the lack of awareness, dearth of skilled veterinarians, and
several regulations pertaining to vaccine use pose a challenge to the market.
Since many farmers work alone and have small herds of cattle. Thus, owing to a
lack of awareness regarding the after-effects of deadly diseases, they place
less emphasis on vaccination. In addition, there is a scarcity of veterinarians
and animal doctors to diagnose diseases and offer effective solutions is also restricting
the market growth.
Furthermore, advancements in vaccine and diagnostic technology provide a scope for market growth. Many companies and research institutions are striving to develop more effective vaccines and better solutions. For example, some companies are working on developing heat-resistant vaccines to minimize the storage costs in cold storage warehouses. Also, several firms provide autogenous (custom-made) vaccinations to combat illnesses. For instance, Phibro Animal Health Corporation is one of the companies offering autogenous vaccinations. In addition, companies such as Idexx Laboratories and Heska Corporation provide diagnostic services (kits/devices) to farm animal producers, veterinary hospitals, and single pet owners, which can assist them in diagnosing their pets at home.
Report scope can be customized per your requirements. Request For Customization
KEY GEOGRAPHIES COVERED:
• North America: United States and Canada
• Europe:
United Kingdom, France, Germany, Spain, Italy, and Rest of Europe
• Asia-Pacific:
China, Japan, India, Australia & New Zealand, South Korea, ASEAN Countries,
and Rest of Asia-Pacific
• Latin America: Brazil, Mexico, Argentina, and Rest of Latin America
SEGMENTATION ANALYSIS – VETERINARY VACCINES MARKET:
• Market by
Disease Type:
o Canine Disease
o Porcine Disease
o Bovine Disease
o Poultry Disease
o Aquaculture Disease
o Other Disease Type
Porcine
Disease is estimated to progress with the highest CAGR during the forecast
period. Porcine diseases are diseases that are seen in
pigs and hogs and pose a threat to them. Some of the porcine diseases are
African Swine Fever (ASF), Classical Swine fever, swine brucellosis,
pseudorabies, etc. To safeguard the species, animal producers and the
government take precautions to ensure the health and safety of these animals.
• Market by
Animal Type:
o Livestock Animals
• Cattle
• Pigs
• Poultry
• Sheep
• Other Livestock Animals
o Companion Animals
• Canine
• Feline
• Equine
o Aquaculture
• Market by
Product Type:
o Attenuated Vaccines
o Inactivated Vaccines
o Toxoid Vaccines
o Conjugate Vaccines
o DNA Vaccines
o Recombinant Vaccines
o Subunit Vaccines
Attenuated
Vaccines lead the market in terms of revenue. Attenuated
vaccines, also known as live attenuated vaccines (LAV), are made from
disease-causing organisms (viruses or bacteria) that have been weakened in the
laboratory. These vaccines elicit a powerful and long-lasting immune response
as they are so similar to the natural infections they help prevent. Only one or
two doses of live vaccinations provide lifetime protection against a pathogen
and the disease it causes. Merck Animal Health is one of the companies that
provide live attenuated vaccines for the immunization of dogs.
COMPETITIVE LANDSCAPE:
The competitive
landscape helps dive into data about the key players in the veterinary vaccines
market. The strategic initiatives for each of the companies considered have
been covered in detail.
Product Launch (March 2022): Ceva Santé Animale
Ceva Santé Animale
launched a sow vaccine against neonatal diarrhea with 7 antigens inside.
Agreement (September 2021): Virbac SA and Jectas Innovators
Key Benefits of the Report:
·
Triton Market Research has a
collective experience of 25-30 years in the industry, with its analysts and
experts encompassing the most infallible research methodology for its market
intelligence and industry analysis.
·
Our research methodology helps
in achieving a broader consensus of the market size, shape, and industry trends
within each industry segment.
·
The strategy adopted in
designing the research methodology includes the amalgamation of the information
assembled from primary and secondary sources, with the assistance of analytical
tools to construct the forecast and predictive models.
·
The scope of the market report
comprises the current scenario of the global veterinary vaccines market, along
with the detailed overview of the industry outlook, market dynamics,
segmentation analysis, regional outlook, and competitive landscape for the
period 2022-2028.
FAQs:
Q 1) Which is the fastest-growing product
type in the veterinary vaccines market?
DNA vaccines are the
fastest-growing product type in the veterinary vaccines market.
Q 2) Which is the fastest-growing animal type in the
veterinary vaccines market?
Companion animals are
the fastest-growing product type in the veterinary vaccines market.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. GLOBAL
VETERINARY VACCINES MARKET – SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON THE VETERINARY VACCINES MARKET
2.2. KEY
INSIGHTS
2.2.1. INCREASING
INNOVATION BY MARKET PARTICIPANTS
2.2.2. ADVANCEMENTS
IN VACCINE AND DIAGNOSTIC TECHNOLOGY
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VALUE
CHAIN ANALYSIS
2.6. KEY
BUYING CRITERIA
2.7. REGULATORY
FRAMEWORK
2.8. VENDOR
SCORECARD
2.9. KEY
MARKET STRATEGIES
2.9.1. MERGERS
& ACQUISITIONS
2.9.2. CONTRACTS
& AGREEMENTS
2.9.3. PRODUCT
LAUNCHES
2.9.4. EXPANSIONS
& DIVESTITURES
2.10. MARKET
DRIVERS
2.10.1. HIGH
VACCINE DEMAND DUE TO INCREASING ANIMAL POPULATION AND DISEASES
2.10.2. GOVERNMENT-ORGANIZED
VACCINATION DRIVES
2.10.3. ADVANCED
VACCINE RESEARCH AND DEVELOPMENT
2.11. MARKET
CHALLENGES
2.11.1. LACK
OF AWARENESS AND SCARCITY OF SKILLED VETERINARIANS
2.11.2. STRINGENT
RULES AND REGULATIONS PERTAINING TO VACCINE USE
2.12. MARKET
OPPORTUNITIES
2.12.1. GROWING
USE OF VACCINES IN THE AMERICAN AND EUROPEAN MARKETS
2.12.2. EXPANSION
OF THE ANIMAL HEALTHCARE MARKET IN THE ASIA-PACIFIC
2.12.3. RISING
DEMAND FOR COMPANION ANIMALS
3. GLOBAL
VETERINARY VACCINES MARKET OUTLOOK – BY ANIMAL TYPE
3.1. LIVESTOCK
ANIMALS
3.1.1. CATTLE
3.1.2. PIGS
3.1.3. POULTRY
3.1.4. SHEEP
3.1.5. OTHER
LIVESTOCK ANIMALS
3.2. COMPANION
ANIMALS
3.2.1. CANINE
3.2.2. FELINE
3.2.3. EQUINE
3.3. AQUACULTURE
4. GLOBAL
VETERINARY VACCINES MARKET OUTLOOK – BY DISEASE TYPE
4.1. CANINE
DISEASE
4.2. PORCINE
DISEASE
4.3. BOVINE
DISEASE
4.4. POULTRY
DISEASE
4.5. AQUACULTURE
DISEASE
4.6. OTHER
DISEASE TYPES
5. GLOBAL
VETERINARY VACCINES MARKET OUTLOOK – BY PRODUCT TYPE
5.1. ATTENUATED
VACCINES
5.2. INACTIVATED
VACCINES
5.3. TOXOID
VACCINES
5.4. CONJUGATE
VACCINES
5.5. DNA
VACCINES
5.6. RECOMBINANT
VACCINES
5.7. SUBUNIT
VACCINES
6. GLOBAL
VETERINARY VACCINES MARKET – REGIONAL OUTLOOK
6.1. NORTH
AMERICA
6.1.1. MARKET
BY ANIMAL TYPE
6.1.1.1. MARKET
BY LIVESTOCK ANIMALS
6.1.1.2. MARKET
BY COMPANION ANIMALS
6.1.2. MARKET
BY DISEASE TYPE
6.1.3. MARKET
BY PRODUCT TYPE
6.1.4. COUNTRY
ANALYSIS
6.1.4.1. UNITED
STATES
6.1.4.2. CANADA
6.2. EUROPE
6.2.1. MARKET
BY ANIMAL TYPE
6.2.1.1. MARKET
BY LIVESTOCK ANIMALS
6.2.1.2. MARKET
BY COMPANION ANIMALS
6.2.2. MARKET
BY DISEASE TYPE
6.2.3. MARKET
BY PRODUCT TYPE
6.2.4. COUNTRY
ANALYSIS
6.2.4.1. UNITED
KINGDOM
6.2.4.2. GERMANY
6.2.4.3. FRANCE
6.2.4.4. SPAIN
6.2.4.5. ITALY
6.2.4.6. REST
OF EUROPE
6.3. ASIA-PACIFIC
6.3.1. MARKET
BY ANIMAL TYPE
6.3.1.1. MARKET
BY LIVESTOCK ANIMALS
6.3.1.2. MARKET
BY COMPANION ANIMALS
6.3.2. MARKET
BY DISEASE TYPE
6.3.3. MARKET
BY PRODUCT TYPE
6.3.4. COUNTRY
ANALYSIS
6.3.4.1. CHINA
6.3.4.2. JAPAN
6.3.4.3. INDIA
6.3.4.4. SOUTH
KOREA
6.3.4.5. ASEAN
COUNTRIES
6.3.4.6. AUSTRALIA
& NEW ZEALAND
6.3.4.7. REST
OF ASIA-PACIFIC
6.4. LATIN
AMERICA
6.4.1. MARKET
BY ANIMAL TYPE
6.4.1.1. MARKET
BY LIVESTOCK ANIMALS
6.4.1.2. MARKET
BY COMPANION ANIMALS
6.4.2. MARKET
BY DISEASE TYPE
6.4.3. MARKET
BY PRODUCT TYPE
6.4.4. COUNTRY
ANALYSIS
6.4.4.1. BRAZIL
6.4.4.2. MEXICO
6.4.4.3. ARGENTINA
6.4.4.4. REST
OF LATIN AMERICA
7. COMPETITIVE
LANDSCAPE
7.1. BOEHRINGER
INGELHEIM INTERNATIONAL GMBH
7.2. BRILLIANT
BIO PHARMA
7.3. CEVA
SANTE ANIMALE
7.4. ELANCO
ANIMAL HEALTH INC
7.5. HESTER
BIOSCIENCES LTD
7.6. HIPRA
7.7. INDIAN
IMMUNOLOGICALS LIMITED
7.8. MERCK
ANIMAL HEALTH
7.9. PHIBRO
ANIMAL HEALTH
7.10. VAXXINOVA
GMBH
7.11. VIRBAC
SA
7.12. ZOETIS
INC
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.2. SOURCES
OF DATA
8.3. RESEARCH
METHODOLOGY
TABLE 1: GLOBAL VETERINARY
VACCINES MARKET, BY REGIONAL OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: VENDOR SCORECARD
TABLE 4: GLOBAL VETERINARY
VACCINES MARKET, BY ANIMAL TYPE, 2022-2028 (IN $ MILLION)
TABLE 5: GLOBAL VETERINARY
VACCINES MARKET, BY LIVESTOCK ANIMALS, 2022-2028 (IN $ MILLION)
TABLE 6: GLOBAL VETERINARY
VACCINES MARKET, BY COMPANION ANIMALS, 2022-2028 (IN $ MILLION)
TABLE 7: GLOBAL VETERINARY
VACCINES MARKET, BY DISEASE TYPE, 2022-2028 (IN $ MILLION)
TABLE 8: GLOBAL VETERINARY
VACCINES MARKET, BY PRODUCT TYPE, 2022-2028 (IN $ MILLION)
TABLE 9: GLOBAL VETERINARY
VACCINES MARKET, BY GEOGRAPHY, 2022-2028 (IN $ MILLION)
TABLE 10: NORTH AMERICA
VETERINARY VACCINES MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 11: NORTH AMERICA
VETERINARY VACCINES MARKET, BY ANIMAL TYPE, 2022-2028 (IN $ MILLION)
TABLE 12: NORTH AMERICA
VETERINARY VACCINES MARKET, BY LIVESTOCK ANIMALS, 2022-2028 (IN $ MILLION)
TABLE 13: NORTH AMERICA
VETERINARY VACCINES MARKET, BY COMPANION ANIMALS, 2022-2028 (IN $ MILLION)
TABLE 14: NORTH AMERICA
VETERINARY VACCINES MARKET, BY DISEASE TYPE, 2022-2028 (IN $ MILLION)
TABLE 15: NORTH AMERICA
VETERINARY VACCINES MARKET, BY PRODUCT TYPE, 2022-2028 (IN $ MILLION)
TABLE 16: EUROPE VETERINARY
VACCINES MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 17: EUROPE VETERINARY
VACCINES MARKET, BY ANIMAL TYPE, 2022-2028 (IN $ MILLION)
TABLE 18: EUROPE VETERINARY
VACCINES MARKET, BY LIVESTOCK ANIMALS, 2022-2028 (IN $ MILLION)
TABLE 19: EUROPE VETERINARY
VACCINES MARKET, BY COMPANION ANIMALS, 2022-2028 (IN $ MILLION)
TABLE 20: EUROPE VETERINARY
VACCINES MARKET, BY DISEASE TYPE, 2022-2028 (IN $ MILLION)
TABLE 21: EUROPE VETERINARY
VACCINES MARKET, BY PRODUCT TYPE, 2022-2028 (IN $ MILLION)
TABLE 22: ASIA-PACIFIC
VETERINARY VACCINES MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 23: ASIA-PACIFIC
VETERINARY VACCINES MARKET, BY ANIMAL TYPE, 2022-2028 (IN $ MILLION)
TABLE 24: ASIA-PACIFIC
VETERINARY VACCINES MARKET, BY LIVESTOCK ANIMALS, 2022-2028 (IN $ MILLION)
TABLE 25: ASIA-PACIFIC VETERINARY
VACCINES MARKET, BY COMPANION ANIMALS, 2022-2028 (IN $ MILLION)
TABLE 26: ASIA-PACIFIC
VETERINARY VACCINES MARKET, BY DISEASE TYPE, 2022-2028 (IN $ MILLION)
TABLE 27: ASIA-PACIFIC
VETERINARY VACCINES MARKET, BY PRODUCT TYPE, 2022-2028 (IN $ MILLION)
TABLE 28: LATIN AMERICA
VETERINARY VACCINES MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 29: LATIN AMERICA
VETERINARY VACCINES MARKET, BY ANIMAL TYPE, 2022-2028 (IN $ MILLION)
TABLE 30: LATIN AMERICA
VETERINARY VACCINES MARKET, BY LIVESTOCK ANIMALS, 2022-2028 (IN $ MILLION)
TABLE 31: LATIN AMERICA
VETERINARY VACCINES MARKET, BY COMPANION ANIMALS, 2022-2028 (IN $ MILLION)
TABLE 32: LATIN AMERICA
VETERINARY VACCINES MARKET, BY DISEASE TYPE, 2022-2028 (IN $ MILLION)
TABLE 33: LATIN AMERICA VETERINARY
VACCINES MARKET, BY PRODUCT TYPE, 2022-2028 (IN $ MILLION)
FIGURE 1: MARKET
ATTRACTIVENESS INDEX
FIGURE 2: VALUE CHAIN ANALYSIS
FIGURE 3: KEY BUYING CRITERIA
FIGURE 4: GLOBAL VETERINARY
VACCINES MARKET, BY ANIMAL TYPE, 2021 & 2028 (IN %)
FIGURE 5: GLOBAL VETERINARY
VACCINES MARKET, BY LIVESTOCK ANIMALS, 2022-2028 (IN $ MILLION)
FIGURE 6: GLOBAL VETERINARY
VACCINES MARKET, BY LIVESTOCK ANIMALS, 2021 & 2028 (IN %)
FIGURE 7: GLOBAL VETERINARY
VACCINES MARKET, BY CATTLE, 2022-2028 (IN $ MILLION)
FIGURE 8: GLOBAL VETERINARY
VACCINES MARKET, BY PIGS, 2022-2028 (IN $ MILLION)
FIGURE 9: GLOBAL VETERINARY
VACCINES MARKET, BY POULTRY, 2022-2028 (IN $ MILLION)
FIGURE 10: GLOBAL VETERINARY
VACCINES MARKET, BY SHEEP, 2022-2028 (IN $ MILLION)
FIGURE 11: GLOBAL VETERINARY
VACCINES MARKET, BY OTHER LIVESTOCK ANIMALS, 2022-2028 (IN $ MILLION)
FIGURE 12: GLOBAL VETERINARY
VACCINES MARKET, BY COMPANION ANIMALS, 2022-2028 (IN $ MILLION)
FIGURE 13: GLOBAL VETERINARY
VACCINES MARKET, BY COMPANION ANIMALS, 2021 & 2028 (IN %)
FIGURE 14: GLOBAL VETERINARY
VACCINES MARKET, BY CANINE, 2022-2028 (IN $ MILLION)
FIGURE 15: GLOBAL VETERINARY
VACCINES MARKET, BY FELINE, 2022-2028 (IN $ MILLION)
FIGURE 16: GLOBAL VETERINARY
VACCINES MARKET, BY EQUINE, 2022-2028 (IN $ MILLION)
FIGURE 17: GLOBAL VETERINARY
VACCINES MARKET, BY AQUACULTURE, 2022-2028 (IN $ MILLION)
FIGURE 18: GLOBAL VETERINARY
VACCINES MARKET, BY DISEASE TYPE, 2021 & 2028 (IN %)
FIGURE 19: GLOBAL VETERINARY
VACCINES MARKET, BY CANINE DISEASE, 2022-2028 (IN $ MILLION)
FIGURE 20: GLOBAL VETERINARY
VACCINES MARKET, BY PORCINE DISEASE, 2022-2028 (IN $ MILLION)
FIGURE 21: GLOBAL VETERINARY
VACCINES MARKET, BY BOVINE DISEASE, 2022-2028 (IN $ MILLION)
FIGURE 22: GLOBAL VETERINARY
VACCINES MARKET, BY POULTRY DISEASE, 2022-2028 (IN $ MILLION)
FIGURE 23: GLOBAL VETERINARY
VACCINES MARKET, BY AQUACULTURE DISEASE, 2022-2028 (IN $ MILLION)
FIGURE 24: GLOBAL VETERINARY
VACCINES MARKET, BY OTHER DISEASE TYPE, 2022-2028 (IN $ MILLION)
FIGURE 25: GLOBAL VETERINARY
VACCINES MARKET, BY PRODUCT TYPE, 2021 & 2028 (IN %)
FIGURE 26: GLOBAL VETERINARY
VACCINES MARKET, BY ATTENUATED VACCINES, 2022-2028 (IN $ MILLION)
FIGURE 27: GLOBAL VETERINARY
VACCINES MARKET, BY INACTIVATED VACCINES, 2022-2028 (IN $ MILLION)
FIGURE 28: GLOBAL VETERINARY
VACCINES MARKET, BY TOXOID VACCINES, 2022-2028 (IN $ MILLION)
FIGURE 29: GLOBAL VETERINARY
VACCINES MARKET, BY CONJUGATE VACCINES, 2022-2028 (IN $ MILLION)
FIGURE 30: GLOBAL VETERINARY
VACCINES MARKET, BY DNA VACCINES, 2022-2028 (IN $ MILLION)
FIGURE 31: GLOBAL VETERINARY
VACCINES MARKET, BY RECOMBINANT VACCINES, 2022-2028 (IN $ MILLION)
FIGURE 32: GLOBAL VETERINARY
VACCINES MARKET, BY SUBUNIT VACCINES, 2022-2028 (IN $ MILLION)
FIGURE 33: GLOBAL VETERINARY
VACCINES MARKET, REGIONAL OUTLOOK, 2021 & 2028 (IN %)
FIGURE 34: UNITED STATES
VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)
FIGURE 35: CANADA VETERINARY
VACCINES MARKET 2022-2028 (IN $ MILLION)
FIGURE 36: UNITED KINGDOM
VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)
FIGURE 37: GERMANY VETERINARY
VACCINES MARKET 2022-2028 (IN $ MILLION)
FIGURE 38: FRANCE VETERINARY
VACCINES MARKET 2022-2028 (IN $ MILLION)
FIGURE 39: SPAIN VETERINARY
VACCINES MARKET 2022-2028 (IN $ MILLION)
FIGURE 40: ITALY VETERINARY
VACCINES MARKET 2022-2028 (IN $ MILLION)
FIGURE 41: REST OF EUROPE
VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)
FIGURE 42: CHINA VETERINARY
VACCINES MARKET 2022-2028 (IN $ MILLION)
FIGURE 43: JAPAN VETERINARY
VACCINES MARKET 2022-2028 (IN $ MILLION)
FIGURE 44: INDIA VETERINARY
VACCINES MARKET 2022-2028 (IN $ MILLION)
FIGURE 45: SOUTH KOREA
VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)
FIGURE 46: ASEAN COUNTRIES
VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)
FIGURE 47: AUSTRALIA & NEW
ZEALAND VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)
FIGURE 48: REST OF
ASIA-PACIFIC VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)
FIGURE 49: BRAZIL VETERINARY
VACCINES MARKET 2022-2028 (IN $ MILLION)
FIGURE 50: MEXICO VETERINARY
VACCINES MARKET 2022-2028 (IN $ MILLION)
FIGURE 51: ARGENTINA
VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)
FIGURE 52: REST OF LATIN
AMERICA VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)